Clinical trial · Interventional
Lymphocytes Subpopulation in Cancer Patients
Lymphocytes Subpopulation and Its Relevance With Tumor Grade and Prognosis in Cancer Patients
NCT02516371CI-TRIAL-00018948CaLymunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to exam the subpopulation of lymphocytes and evaluate the clinico-pathologic correlations.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| lymphocyte | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- lymphocytes
- description
- To evaluate the subpopulation of lymphocytes in cancer patients
- interventionNames
- Other: lymphocyte
Primary outcomes (1)
- measure
- response rate after cancer treatment with chemotherapy
- timeFrame
- 6 months after chemotherapy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. cancer patients of Uijeongbu St. Mary's Hospital 2. never treated with chemotherapy 3. Age between 20\~80 years- Exclusion Criteria: 1. treated with chemotherapy before 2. No informed consent form
References
Publications (0)
Data not yet available
No reference posted for this study.